TY-51469

• Description:

  TY-51469 is a chymase inhibitor with IC50s for simian and human chymases of 0.4 and 7.0 nM, respectively.

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319, H335

• Target:

  Proteasome

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/TY_51469.html

• Purity:

  99.79

• Solubility:

  DMSO : 33.33 mg/mL (ultrasonic)

• Smiles:

  O=C (C1=CSC (C2=CC=C (NS (=O) (C3=C (C) C4=CC (F) =CC=C4S3) =O) C (S (=O) (C) =O) =C2) =N1) O

• Molecular Formula:

  C20H15FN2O6S4

• Molecular Weight:

  526.60

• Precautions:

  H302, H315, H319, H335

• References & Citations:

  [1]Takato H, et al. The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice. Expert Opinion on Therapeutic Targets Volume 15, 2011 - Issue 4.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C, 3 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  603987-59-3